SCHEMBL6157035

SCHEMBL6157035

CC(=O)OC1CC(=O)N(Cc2ccc(Oc3ccc([N+](=O)[O-])cc3)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.53
MGLL Q99685 1/20 0.44
ALDH1A1 P00352 2/20 0.42
ATM Q13315 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MAOB P27338 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6157838 0.84 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2KMT2AL3MBTL1HTT
SCHEMBL6158356 0.83 TDP1 (0.52) TDP1MGLLALDH1A1ATMNPC1
SCHEMBL6158475 0.83 TDP1 (0.55) TDP1MGLLALDH1A1ATMNPC1
SCHEMBL28006519 0.83 ALDH1A1 (0.54) ALDH1A1SIRT2SIRT1SMN1; SMN2KMT2A
SCHEMBL6159393 0.83 ALDH1A1 (0.54) ALDH1A1NPC1RAB9ASIRT1SMN1; SMN2
SCHEMBL6158572 0.81 TDP1 (0.53) TDP1MGLLALDH1A1ATMNPC1
SCHEMBL6157462 0.80 PGR (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6780636 0.79 ALDH1A1 (0.39) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL27495098 0.79 HPGD (0.54) TDP1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6158600 0.79 MTNR1B (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 TDP1 3844/4885MGLL 4739/4885ALDH1A1 905/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 TDP1 3868/4885MGLL 4776/4885ALDH1A1 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.